Tuesday, September 26, 2017

Stimulant Medication Use Linked to Sharp Increase in BMI by Eighth Grade

New evidence suggests that children on ADHD medication may have stunted growth initially but more rapid increases in body mass over time.

Leading Researchers Critique Current Paradigm for Studying ‘Schizophrenia’ Risk

Re-conceptualizing the Clinical-High-Risk/Ultra-High-Risk Paradigm: A critique and reappraisal

What Happens When You Stop Taking Psychiatric Medications

From Pacific Standard: A new study surveyed people who have come off psychiatric medications to come up with information doctors can use to help support their...
elephant

Psychiatry Ignores an Elephant in the Room

Large cohort studies of people with a first-episode psychosis provide a unique opportunity for finding out why so many young people with schizophrenia spectrum disorders die at a young age. However, it seems that those psychiatrists who have access to the mortality data generally do not want the facts to come out.

Marijuana Research: Overcoming the Barriers

From APA Science Advocacy: As an increasing number of states are beginning to legalize the medicinal and/or recreational use of marijuana, it is clear that...

Coroner Finds Anti-Smoking Drug Contributed to Man’s Suicide

From ABC: A Queensland Coroner has found that the anti-smoking drug Champix played a role in the suicide of a 22-year-old man, Timothy John, who...

More Follow Up Needed for Drugs Granted Accelerated FDA Approval

Drugs to treat serious or life-threatening conditions can receive accelerated FDA approval, but may expose patients to increased safety risks and reduced efficacy.

Study Finds Antidepressants Increase Risk of Death

From the New York Post: A recent study found that taking antidepressant drugs increases the risk of death by 33 percent. Those who take antidepressants were...

Replacing Pain with Pain: Hazards of Antidepressant Use for Chronic Pain Relief

The paradox of relieving chronic pain with an antidepressant (and a new set of symptoms).

Lawsuit Over a Suicide Points to a Risk of Antidepressants

From The New York Times: The recent trial of Wendy Dolin, whose husband died of suicide after starting the antidepressant paroxetine, demonstrates our need for more...

FDA Approves Drug for the Annoyingly Cheerful (The Onion)

From The Onion: "Made by Pfizer, Despondex is the first drug designed to treat the symptoms of excessive perkiness." Video →­

The Most Promoted Drugs are Those with Little Therapeutic Value, Study Finds

Majority of top-selling and most promoted drugs in Canada are rated as having very limited safety and efficacy.

The Smartphone Psychiatrist

In this piece for The Atlantic, David Dobbs delves into the life of former NIMH director Thomas Insel, his critiques of research within the field of...

Antidepressants are Accumulating in Fish Brains in the Wild

From the International Business Times: Americans are taking so many antidepressants that they are showing up in wild fish. Ten different species of fish in...

Proove Biosciences Sells Off Assets as CEO Departs

From STAT: Proove Biosciences, which sold dubious DNA tests to predict opioid addiction risk, has been placed into court-ordered receivership for restructuring and asset sale. Experts...

Part V: The Michelle Carter Texting Trial Becomes a Witch Hunt

In Parts I-IV, I discuss how the DA succeeded in gaining the conviction by means of highly emotional and at times misleading and untruthful manipulations in public and in the courtroom. Here I want to look more closely at the DA’s motivation and other activities. Was it a personal vendetta?

Belief in a Favorable Future May Undermine that Future

People who are more likely to believe that others’ views will change to match their own over time are less likely to engage in actions to facilitate that change

MDMA Crossed a Hurdle on the Path to Being Legally Prescribed

From Yahoo! Finance: The Multidisciplinary Association for Psychedelic Studies (MAPS) has passed a major hurdle on the path to getting MDMA approved for medical use....

Researchers Question Add-On Treatment for ‘Schizophrenia’

A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.

Why Addiction Language is Harmful

In this video for Benzo Brains, Jocelyn Pedersen explains why addiction is harmful to benzodiazepine survivors and differentiates benzodiazepine associated disability (BAD) from benzodiazepine addiction.

Deprescribing: How to be on Less Medication for Healthier Aging

In this post for Better Health While Aging, Dr. Leslie Kernisan discusses the importance of making sure that older adults are taking the minimum amount...

Inappropriate Use of Antipsychotics on Adults with Intellectual and Developmental Disabilities

One-third of adults with an intellectual or developmental disability are dispensed antipsychotics, despite having no existing psychiatric diagnosis.

The Real Opioid Emergency

From The New York Times: In recent years, politicians have shown increased awareness of the opioid epidemic and have made statements about the need for treatment,...

The Concept of Schizophrenia is Coming to an End – Here’s Why

From The Conversation: Many researchers are beginning to acknowledge that the concept of "schizophrenia" as a discrete, hopeless, and deteriorating brain disease does not exist. In...

Abilify: The Drug That Could Gamble Your Life Away

On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...

Follow Us

19,394FansLike
10,244FollowersFollow
1,376SubscribersSubscribe